The Indian health ministry has maintained its position for the last 10 years. At least formally, with the Supreme Court, the Parliament and the media. It wants to upgrade the three public vaccine manufacturers to supply vaccines of impeccable quality at a low price. Now that the government companies have risen from the ashes as competent vaccine producers, the health ministry needs to make a choice. Are they still a worthy contender for the now Rs 9,451-crore ($1.44 billion) national vaccination programme?

The three public sector undertakings (PSUs)—Central Research Institute (CRI), Kasauli, BCG Vaccine Laboratory (BCGVL), Chennai and Pasteur Institute of India (PII), Coonoor—were shut down in January 2008.


Ruhi Kandhari

Ruhi writes on the impact of healthcare policies, trends in the healthcare sector and developments on the implementation of Electronic Health Records in India. She has an M. Sc. in Development Studies from the London School of Economics.

View Full Profile

Sign up to our India edition to read this story instantly

To sign up, you’ll create an account that will give you access to a new free story published once a week and archive of 214+ previously published free stories from our India edition. You’ll also receive one email every morning from us introducing the day’s story.

If you’ve already signed up, just enter your email below or login using Facebook or Google.